Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Three new option listings on July 10th » 08:30
07/10/20
07/10
08:30
07/10/20
08:30
EVOK

Evoke Pharma

$3.56 /

-0.03 (-0.84%)

, FREE

FreeSeas

$7.66 /

+0.07 (+0.92%)

, IDYA

Ideaya Biosciences

$13.36 /

-0.44 (-3.19%)

New option listings for…

New option listings for July 10th include Evoke Pharma (EVOK), Whole Earth Brands Inc (Class A Stock) (FREE), and IDEAYA Biosciences Inc (IDYA).

ShowHide Related Items >><<
IDYA Ideaya Biosciences
$13.36 /

-0.44 (-3.19%)

EVOK Evoke Pharma
$3.56 /

-0.03 (-0.84%)

EVOK Evoke Pharma
$3.56 /

-0.03 (-0.84%)

06/22/20 H.C. Wainwright
Evoke Pharma upgraded to Buy from Neutral at H.C. Wainwright
FREE FreeSeas
$7.66 /

+0.07 (+0.92%)

IDYA Ideaya Biosciences
$13.36 /

-0.44 (-3.19%)

06/17/20 H.C. Wainwright
Ideaya Biosciences price target raised to $22 from $13 at H.C. Wainwright
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
06/16/20 Oppenheimer
Ideaya Biosciences price target raised to $25 from $17 at Oppenheimer
04/06/20
Fly Intel: Top five analyst initiations
IDYA Ideaya Biosciences
$13.36 /

-0.44 (-3.19%)

EVOK Evoke Pharma
$3.56 /

-0.03 (-0.84%)

  • 18
    Jun
IDYA Ideaya Biosciences
$13.36 /

-0.44 (-3.19%)

EVOK Evoke Pharma
$3.56 /

-0.03 (-0.84%)

Conference/Events
International Aids Society to hold a virtual conference » 04:55
07/10/20
07/10
04:55
07/10/20
04:55
ABT

Abbott

$93.68 /

+1.11 (+1.20%)

, BDX

Becton Dickinson

$258.57 /

+5.92 (+2.34%)

, GILD

Gilead

$74.67 /

-0.96 (-1.27%)

, HOLX

Hologic

$57.45 /

-0.13 (-0.23%)

, MRK

Merck

$76.70 /

-1.17 (-1.50%)

, OSUR

OraSure

$13.86 /

+0.495 (+3.71%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$13.86 /

+0.495 (+3.71%)

MRK Merck
$76.70 /

-1.17 (-1.50%)

HOLX Hologic
$57.45 /

-0.13 (-0.23%)

GILD Gilead
$74.67 /

-0.96 (-1.27%)

BDX Becton Dickinson
$258.57 /

+5.92 (+2.34%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$258.57 /

+5.92 (+2.34%)

07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
GILD Gilead
$74.67 /

-0.96 (-1.27%)

04:49 Today Stifel
Galapagos downgraded to Hold from Buy at Stifel
06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
HOLX Hologic
$57.45 /

-0.13 (-0.23%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$76.70 /

-1.17 (-1.50%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$13.86 /

+0.495 (+3.71%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$13.86 /

+0.495 (+3.71%)

MRK Merck
$76.70 /

-1.17 (-1.50%)

HOLX Hologic
$57.45 /

-0.13 (-0.23%)

GILD Gilead
$74.67 /

-0.96 (-1.27%)

BDX Becton Dickinson
$258.57 /

+5.92 (+2.34%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

  • 03
    Jun
  • 21
    May
MRK Merck
$76.70 /

-1.17 (-1.50%)

GILD Gilead
$74.67 /

-0.96 (-1.27%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

OSUR OraSure
$13.86 /

+0.495 (+3.71%)

MRK Merck
$76.70 /

-1.17 (-1.50%)

HOLX Hologic
$57.45 /

-0.13 (-0.23%)

GILD Gilead
$74.67 /

-0.96 (-1.27%)

BDX Becton Dickinson
$258.57 /

+5.92 (+2.34%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

MRK Merck
$76.70 /

-1.17 (-1.50%)

HOLX Hologic
$57.45 /

-0.13 (-0.23%)

GILD Gilead
$74.67 /

-0.96 (-1.27%)

ABT Abbott
$93.68 /

+1.11 (+1.20%)

Yesterday
Hot Stocks
MoneyGram reports 106% year-over-year digital transaction growth in June » 11:52
07/09/20
07/09
11:52
07/09/20
11:52
MGI

MoneyGram

$2.86 /

-0.08 (-2.72%)

MoneyGram International…

MoneyGram International reported 106% year-over-year digital transaction growth in June, stating that "strong consumer demand for its leading digital capabilities and customer-centric app continues to grow." Each component of the digital business - MoneyGram Online, digital partnerships, and sends directly to a wallet or bank account - contributed to the strong overall digital growth in June, MoneyGram stated. The company also announced the expansion of its consumer direct channel and online presence to Iceland.

ShowHide Related Items >><<
MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

06/10/20
Fly Intel: Top five analyst downgrades
06/10/20 BofA
Western Union downgraded to Neutral from Buy at BofA
06/02/20 BTIG
Western Union-Money Gram review could note more online competition, says BTIG
04/06/20 Barclays
MoneyGram price target lowered to $1 from $2 at Barclays
MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

MGI MoneyGram
$2.86 /

-0.08 (-2.72%)

Hot Stocks
Ideaya doses first patient in Phase 1 combination study of IDE196/binimetinib » 06:06
07/09/20
07/09
06:06
07/09/20
06:06
IDYA

Ideaya Biosciences

$13.80 /

+0.32 (+2.37%)

, PFE

Pfizer

$33.76 /

-0.27 (-0.79%)

IDEAYA Biosciences (IDYA)…

IDEAYA Biosciences (IDYA) announced First-Patient-In, or FPI, in the Phase 1 combination study of IDE196 and binimetinib, a MEK inhibitor, in metastatic uveal melanoma, or MUM. IDEAYA said in a release, "The clinical combination of IDE196 and binimetinib is being evaluated by IDEAYA with binimetinib being supplied by Pfizer pursuant to a clinical trial collaboration and supply agreement. In the MUM setting, IDEAYA's clinical development strategy focuses on rational combinations, including MEK, and supporting studies through collaborations, such as the Pfizer (PFE) clinical trial collaboration and supply agreement. IDEAYA's strategic objective is to enhance the clinical activity of IDE196 through potential synergistic combinations. In the non-MUM GNAQ/11 hotspot mutation basket trial, including skin melanoma, IDEAYA will continue to evaluate IDE196 monotherapy and potential combinations, such as with binimetinib. IDEAYA anticipates interim data from the MEK combination study in late 2021 to early 2022, at which time the company will evaluate a potential registrational path for MUM and a potential partnership."

ShowHide Related Items >><<
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

IDYA Ideaya Biosciences
$13.80 /

+0.32 (+2.37%)

IDYA Ideaya Biosciences
$13.80 /

+0.32 (+2.37%)

06/17/20 H.C. Wainwright
Ideaya Biosciences price target raised to $22 from $13 at H.C. Wainwright
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
06/16/20 Oppenheimer
Ideaya Biosciences price target raised to $25 from $17 at Oppenheimer
04/06/20
Fly Intel: Top five analyst initiations
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

IDYA Ideaya Biosciences
$13.80 /

+0.32 (+2.37%)

  • 18
    Jun
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

IDYA Ideaya Biosciences
$13.80 /

+0.32 (+2.37%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

Conference/Events
International Aids Society to hold a virtual conference » 04:55
07/09/20
07/09
04:55
07/09/20
04:55
ABT

Abbott

$92.57 /

+0.21 (+0.23%)

, BDX

Becton Dickinson

$252.65 /

+1.24 (+0.49%)

, GILD

Gilead

$75.63 /

-0.84 (-1.10%)

, HOLX

Hologic

$57.58 /

+0.72 (+1.27%)

, MRK

Merck

$77.87 /

-0.77 (-0.98%)

, OSUR

OraSure

$13.36 /

+0.37 (+2.85%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
GILD Gilead
$75.63 /

-0.84 (-1.10%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
HOLX Hologic
$57.58 /

+0.72 (+1.27%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$77.87 /

-0.77 (-0.98%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

  • 03
    Jun
  • 21
    May
MRK Merck
$77.87 /

-0.77 (-0.98%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

Wednesday
Conference/Events
International Aids Society to hold a virtual conference » 04:55
07/08/20
07/08
04:55
07/08/20
04:55
ABT

Abbott

$92.36 /

-0.62 (-0.67%)

, BDX

Becton Dickinson

$251.41 /

+1.035 (+0.41%)

, GILD

Gilead

$76.47 /

-0.31 (-0.40%)

, HOLX

Hologic

$56.86 /

-0.99 (-1.71%)

, MRK

Merck

$78.64 /

-0.95 (-1.19%)

, OSUR

OraSure

$12.99 /

+0.375 (+2.97%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
GILD Gilead
$76.47 /

-0.31 (-0.40%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
HOLX Hologic
$56.86 /

-0.99 (-1.71%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$78.64 /

-0.95 (-1.19%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

  • 03
    Jun
  • 21
    May
MRK Merck
$78.64 /

-0.95 (-1.19%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

Tuesday
Conference/Events
OraSure participates in a conference call hosted by Lake Street » 11:25
07/07/20
07/07
11:25
07/07/20
11:25
OSUR

OraSure

$12.65 /

+0.035 (+0.28%)

Conference call with CEO…

Conference call with CEO Tang and CFO Cuca to be held on July 7 at 12 pm hosted by Lake Street.

ShowHide Related Items >><<
OSUR OraSure
$12.65 /

+0.035 (+0.28%)

OSUR OraSure
$12.65 /

+0.035 (+0.28%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.65 /

+0.035 (+0.28%)

  • 03
    Jun
OSUR OraSure
$12.65 /

+0.035 (+0.28%)

Conference/Events
International Aids Society to hold a virtual conference » 09:24
07/07/20
07/07
09:24
07/07/20
09:24
ABT

Abbott

$92.98 /

+0.73 (+0.79%)

, BDX

Becton Dickinson

$250.38 /

+5.285 (+2.16%)

, GILD

Gilead

$76.78 /

+0.47 (+0.62%)

, HOLX

Hologic

$57.85 /

-0.02 (-0.03%)

, MRK

Merck

$79.59 /

+0.8 (+1.02%)

, OSUR

OraSure

$12.62 /

+0.605 (+5.04%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

MRK Merck
$79.59 /

+0.8 (+1.02%)

HOLX Hologic
$57.85 /

-0.02 (-0.03%)

GILD Gilead
$76.78 /

+0.47 (+0.62%)

BDX Becton Dickinson
$250.38 /

+5.285 (+2.16%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$250.38 /

+5.285 (+2.16%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
GILD Gilead
$76.78 /

+0.47 (+0.62%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
HOLX Hologic
$57.85 /

-0.02 (-0.03%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$79.59 /

+0.8 (+1.02%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

MRK Merck
$79.59 /

+0.8 (+1.02%)

HOLX Hologic
$57.85 /

-0.02 (-0.03%)

GILD Gilead
$76.78 /

+0.47 (+0.62%)

BDX Becton Dickinson
$250.38 /

+5.285 (+2.16%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

  • 03
    Jun
  • 21
    May
MRK Merck
$79.59 /

+0.8 (+1.02%)

GILD Gilead
$76.78 /

+0.47 (+0.62%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

OSUR OraSure
$12.62 /

+0.605 (+5.04%)

MRK Merck
$79.59 /

+0.8 (+1.02%)

HOLX Hologic
$57.85 /

-0.02 (-0.03%)

GILD Gilead
$76.78 /

+0.47 (+0.62%)

BDX Becton Dickinson
$250.38 /

+5.285 (+2.16%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

MRK Merck
$79.59 /

+0.8 (+1.02%)

HOLX Hologic
$57.85 /

-0.02 (-0.03%)

GILD Gilead
$76.78 /

+0.47 (+0.62%)

ABT Abbott
$92.98 /

+0.73 (+0.79%)

Conference/Events
OraSure participates in a conference call hosted by Lake Street » 04:55
07/07/20
07/07
04:55
07/07/20
04:55
OSUR

OraSure

$12.62 /

+0.605 (+5.04%)

Conference call with CEO…

Conference call with CEO Tang and CFO Cuca to be held on July 7 at 12 pm hosted by Lake Street.

ShowHide Related Items >><<
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

OSUR OraSure
$12.62 /

+0.605 (+5.04%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

  • 03
    Jun
OSUR OraSure
$12.62 /

+0.605 (+5.04%)

Monday
Conference/Events
OraSure participates in a conference call hosted by Lake Street » 09:19
07/06/20
07/06
09:19
07/06/20
09:19
OSUR

OraSure

$12.01 /

+0.76 (+6.76%)

Conference call with CEO…

Conference call with CEO Tang and CFO Cuca to be held on July 7 at 12 pm hosted by Lake Street.

ShowHide Related Items >><<
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

OSUR OraSure
$12.01 /

+0.76 (+6.76%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

  • 03
    Jun
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.